 |
|
Reduction of the cetrorelix dose in a multiple-dose antagonist protocol and its impact on pregnancy rate and affordability: A randomized controlled multicenter study
Ayman S Dawood, Adel Algergawy, Ahmed Elhalwagy
Clin Exp Reprod Med. 2017;44(4):232-238. Published online 2017 Dec 31 DOI: https://doi.org/10.5653/cerm.2017.44.4.232
|
|
Citations to this article as recorded by
 A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology
Michiko Hamada, Michiharu Horikawa, Chie Ensaka, Megumi Enomoto, Rena Ishii, Rena Toriumi, Naoyuki Tachibana, Yuji Taketani
Reproductive Medicine and Biology.2022;[Epub] CrossRef
|